Jan 11, 2021 / 03:50PM GMT
Tycho W. Peterson - JPMorgan Chase & Co, Research Division - Senior Analyst
Okay. Great. We're going to go ahead and kick it off. I'm Tycho Peterson from the Life Sciences team. It's my pleasure to introduce our next company this morning, Guardant. (Operator Instructions)
And with that, I'll turn it over to Helmy.
Helmy Eltoukhy - Guardant Health, Inc. - Co-Founder, CEO & Director
Thank you, Tycho, for the opportunity to present today at the conference. Okay. If we can bring the presentation on. Very good. Well, next slide. Please note our forward-looking statement. Next.
A little less than a decade ago, we had a dream that liquid biopsies could be at the center of transforming cancer care across the entire continuum from early cancer screening to recurrence monitoring and to therapy selection, bringing to clinical practice, a powerful new precision oncology paradigm.
Indeed, we believe that liquid biopsies could serve as a driving force to unlocking critical data that could accelerate our collective understanding of how
Guardant Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers